microbiota-based formulation RBX7455

{
  "id": "MLC-T-ONC-015168",
  "term": "microbiota-based formulation RBX7455",
  "field": "Oncology and biomedicine",
  "definition": "An orally administered, microbiota-based therapeutic composed of a processed and lyophilized form of the microbiota suspension RBX2660, consisting of live, human-derived bacteria prepared from donated human stool, with potential immunomodulatory activity. Upon administration, microbiota-based formulation RBX7455 may restore the unhealthy, altered gut microbiome, enhance the microbial diversity and function in the gastrointestinal (GI) tract and may re-establish a healthy microbiome in the GI tract. This may enhance the patients' immunological activity.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/microbiota-based-formulation-rbx7455/"
}